GV

Geeta Vani Namani

Active Director Director DIN 11307253
DIN 11307253 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Geeta Vani Namani

Data last updated:

Geeta Vani Namani is a Director at Metacell Life Sciences Private Limited (since 2025).

DIN 11307253
Primary Designation Director
First Appointment 19 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Sep 20252025Active

Board colleagues of Geeta Vani Namani

Directorship timeline

Open interactive timeline →
Metacell Life Sciences Private Limited
Premium access

Shareholding and investment profile for Geeta Vani Namani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geeta Vani Namani

Geeta Vani Namani currently holds 1 directorship: Metacell Life Sciences Private Limited (Director, since 19 Sep 2025).

Geeta Vani Namani was first appointed on 19 Sep 2025 as Director at Metacell Life Sciences Private Limited.

The current boards of Geeta Vani Namani's companies include Guduri Atharv (Metacell Life Sciences Private Limited), Kusuma Sree Laxmi (Metacell Life Sciences Private Limited), Madipeddi Rajita (Metacell Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available